In-Process Quality Control (IPQC) Tests for Tablets – A Complete Guide.
Introduction
In the pharmaceutical industry, quality is non-negotiable. Tablets remain the most common dosage form, and ensuring their safety, efficacy, and uniformity is essential. To achieve this, In-Process Quality Control (IPQC) tests for tablets are conducted during different stages of manufacturing.
Unlike finished product testing, which happens after the batch is complete, IPQC tests are performed during production. These checks help detect problems early, reduce wastage, maintain compliance with Good Manufacturing Practices (GMP), and ensure consistent quality.
This guide explains all IPQC tests for tablets, their purpose, procedure, acceptance criteria, and regulatory significance in detail.
What is IPQC in Pharmaceuticals?
In-Process Quality Control (IPQC) refers to the checks and tests performed at different stages of manufacturing to ensure that intermediate and final products meet the required quality standards.
- Conducted during tablet production (granulation, compression, coating, and packaging).
- Ensures batch consistency and regulatory compliance.
- Helps in identifying deviations before batch rejection.
Importance of IPQC in Tablet Manufacturing
- Consistency in quality – Ensures every tablet is within acceptable limits.
- Regulatory compliance – Meets guidelines by WHO, USFDA, MHRA, and GMP.
- Early detection of errors – Prevents large-scale batch failure.
- Patient safety – Guarantees correct dose delivery.
- Cost reduction – Saves resources by minimizing rework and rejection.
IPQC vs Finished Product Testing
| Parameter | IPQC (In-Process) | Finished Product Testing |
|---|---|---|
| Stage | During production | After production |
| Purpose | Prevent deviations early | Final confirmation |
| Frequency | Continuous/Periodic | Once per batch |
| Examples | Tablet weight variation, hardness | Dissolution, Assay |
IPQC Tests for Tablets – Step by Step
Now let’s discuss major in-process tests performed during tablet manufacturing.
1. Appearance / Visual Inspection
- Objective: To check for physical defects (color, cracks, contamination).
- Method: Visual check under adequate light.
- Acceptance: Tablets should be uniform in shape, free from cracks, spots, or black particles.
2. Tablet Weight Variation Test
- Why: Ensures each tablet contains the correct drug dose.
- Method: Weigh 20 tablets individually → Calculate average → Compare individual weights with pharmacopoeial limits.
- Limits (as per IP/BP/USP):
| Average Tablet Weight | % Deviation Allowed |
|---|---|
| < 80 mg | ±10% |
| 80 – 250 mg | ±7.5% |
| > 250 mg | ±5% |
3. Hardness (Crushing Strength) Test
- Objective: To measure mechanical strength of tablets.
- Method: Test 10 tablets in a Monsanto, Pfizer, or Schleuniger Hardness Tester.
- Typical Range: 4–8 kg/cm² (depending on product type).
- Importance: Too hard → poor disintegration. Too soft → breakage during handling.
4. Thickness Test
- Purpose: To check tablet size uniformity.
- Instrument: Vernier caliper or digital micrometer.
- Limit: ±5% variation allowed.
5. Friability Test
- Why: Checks resistance to abrasion during handling/packaging.
- Method: 20 tablets → Friabilator → 100 revolutions at 25 rpm → Weigh before and after.
- Limit: ≤1% weight loss (as per USP).
6. Disintegration Test (DT)
- Objective: To check how fast tablets break into smaller particles.
- Method: USP Disintegration Apparatus (basket-rack assembly) with 6 tubes in water (37°C).
- Limit:
- Uncoated tablets → ≤15 minutes
- Film-coated → ≤30 minutes
- Enteric-coated → No disintegration in 0.1N HCl for 2 hours, then ≤60 minutes in buffer pH 6.8.
7. Content Uniformity (CU)
- Purpose: Ensures each tablet contains API within limits.
- Method: 10 tablets are assayed individually.
- Acceptance: 85%–115% of label claim with RSD ≤6%.
8. Moisture Content Test
- Objective: Prevent microbial growth, degradation, and sticking issues.
- Method: Loss on Drying (LOD) / Karl Fischer Titration.
- Limit: Usually ≤2% w/w (product specific).
9. Lubrication & Blend Uniformity Check
- Ensures proper distribution of lubricants and API.
- Checked by sampling blend and testing assay/uniformity.
10. Identification & Assay of API (Quick Tests)
- Performed randomly during compression.
- Rapid methods (HPLC/UV/IR) confirm correct drug.
IPQC During Tablet Coating
- Weight Gain Monitoring – Ensures uniform coating thickness.
- Color Consistency – Checked visually.
- Defect Monitoring – For peeling, roughness, mottling, orange peel effect.
- Disintegration / Dissolution Check – Performed on coated tablets.
IPQC Tests During Packaging
- Blister integrity test
- Strip seal test
- Carton checking for batch coding, labeling, and leaflet insertion
Regulatory Guidelines for IPQC
- WHO GMP – IPQC is mandatory in all pharmaceutical plants.
- ICH Q8 & Q10 – Stress on process monitoring and continuous improvement.
- USFDA 21 CFR Part 211 – Requires IPQC documentation and batch release justification.
- Indian Pharmacopoeia / USP / BP – Define test procedures and limits.
Documentation of IPQC
- Every IPQC test must be recorded in Batch Manufacturing Record (BMR).
- Deviations should be investigated and approved by Quality Assurance (QA).
- Results are cross-verified before batch release.
Common Problems Detected by IPQC
| Problem | Cause | Preventive IPQC Check |
|---|---|---|
| Weight variation | Poor granule flow | Compression weight check |
| Capping / Lamination | Low binder, high compression | Hardness, thickness test |
| Picking / Sticking | Moist granules, poor lubrication | Moisture content, lubrication check |
| Poor dissolution | Over-hard tablets | Hardness & DT monitoring |
Best Practices for IPQC in Tablet Manufacturing
- Train operators on GMP and IPQC procedures.
- Use automated equipment for real-time monitoring.
- Establish SOPs for each IPQC test.
- Perform periodic calibration of IPQC instruments.
- Integrate PAT (Process Analytical Technology) for advanced monitoring.
FAQs on IPQC Tests for Tablets
Q1. Who performs IPQC in pharma?
👉 IPQC officers and production chemists under QA supervision.
Q2. How often should IPQC tests be done?
👉 At regular intervals during granulation, compression, coating, and packaging. Frequency is batch-specific.
Q3. Is IPQC mandatory for all tablets?
👉 Yes, regulatory bodies like FDA, GMP, and WHO mandate in-process checks for every batch.
Q4. What happens if a batch fails IPQC?
👉 Production is stopped, deviation is raised, investigation is done, and corrective action is taken.
Q5. Which is the most critical IPQC test for tablets?
👉 Weight variation, hardness, friability, and disintegration are considered most critical.
Conclusion
In-Process Quality Control (IPQC) tests for tablets are the backbone of pharmaceutical manufacturing. They ensure that every tablet reaching the patient is safe, effective, and consistent in quality.
From weight variation, hardness, friability, disintegration, dissolution, to content uniformity, each test plays a crucial role in safeguarding patient health.
Pharmaceutical companies must follow GMP guidelines, regulatory standards, and maintain proper documentation to ensure compliance and build trust in their medicines.
By implementing robust IPQC practices, pharma industries can reduce rejections, save costs, and deliver world-class healthcare solutions.
